| Literature DB >> 6136838 |
B L Evatt, S F Stein, D P Francis, D N Lawrence, M F McLane, J S McDougal, T H Lee, T J Spira, C Cabradilla, J I Mullens, M Essex.
Abstract
Human T cell leukaemia virus (HTLV), HTLV proviral DNA, and antibodies to HTLV or a related agent have recently been detected in patients with acquired immunodeficiency syndrome (AIDS). Antibodies against HTLV-related antigens were assayed by means of indirect living cell immunofluorescence of HTLV-infected cells in sera recently collected from Georgia haemophiliacs and in sera collected between 1976 and 1981 from New York haemophiliacs. 5 of 45 Georgia haemophiliacs and 8 of 48 New York haemophiliacs had antibodies to HTLV-associated cell membrane antigen (HTLV-MA). None of the control Georgia patients on haemodialysis or with chronic hepatitis had detectable antibodies. The 5 haemophiliac patients from Georgia with HTLV-MA had significantly fewer T4 lymphocytes than similar HTLV-MA-negative patients. There were no other significant immunological differences between these groups. These data suggest that transfusions with blood products may expose haemophiliacs to a substantial risk of acquiring HTLV or a related virus.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6136838 DOI: 10.1016/s0140-6736(83)92245-6
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321